Titre : | California drug courts: Outcomes, costs and promising practices : An overview of phase II in a statewide study (2006) |
Titre traduit : | (Les tribunaux affectés à la drogue en Californie : résultats, coûts et pratiques prometteuses. Vue panoramique de la phase II d' une étude à l'échelle nationale) |
Auteurs : | S. M. CAREY ; M. FINIGAN ; CRUMPTON D. ; M. WALLER |
Type de document : | Article : Périodique |
Dans : | Journal of Psychoactive Drugs (Vol.38, Suppl.3, 2006) |
Article en page(s) : | 345-356 |
Note générale : |
Journal of Psychoactive Drugs, 2006, 38(Suppl. 3), 345-356 |
Langues: | Anglais |
Discipline : | SHS (Sciences humaines et sociales / Humanities and social sciences) |
Mots-clés : |
Thésaurus mots-clés JUSTICE ; EVALUATION ; RECHERCHE ; COUT SOCIAL ; INTERNETThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : The rapid expansion of drug courts in California and the state's uncertain fiscal climate highlighted the need for definitive cost information on drug court programs. This study focused on creating a research design that can be utilized for statewide and national cost-assessment of drug courts by conducting in-depth case studies of the costs and benefits in nine adult drug courts in California. A Transactional Institutional Costs Analysis (TICA) approach was used, allowing researchers to calculate costs based on every individual's transactions within the drug court or the traditional criminal justice system. This methodology also allows the calculation of costs and benefits by agency (e.g., Public Defender's office, court, District Attorney). Results in the nine sites showed that the majority of agencies save money in processing an offender though drug court. Overall, for these nine study sites, participation in drug court saved the state over $9 million in criminal justice and treatment costs due to lower recidivism in drug court participants. Based on the lessons learned in Phases I and II, Phase III of this study focuses on the creation of a web-based drug court cost self-evaluation tool (DC-CSET) that drug courts can use to determine their own costs and benefits. (Author' s abstract) |
Note de contenu : | fig. ; tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 23 |
Affiliation : | Etats-Unis. United States. |
Numéro Toxibase : | 1301887 |
Centre Emetteur : | 13 OFDT |
Cote : | Abonnement |
Accueil